MedTrace Logo

Rhythmic Auditory Stimulation and Walking Speed in the 6-minute Walk Test

NCT03905161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2020-08-12

No results posted yet for this study

Summary

The aim of this study is to investigate if rhythmic auditory stimulation can influence walking speed, during a 6MWT in patients with myasthenia gravis (MG).

Conditions

Interventions

OTHER

6-minute walk test

The 6-minute walk test (6MWT) is widely used in the clinic to measure treatment efficacy and disease progression in patients with neuromuscular diseases and is found valid and reliable to measure decrease in walking speed for neuromuscular patients.

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Linda K Andersen · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-10
Primary Completion
2020-01-10
Completion
2020-01-10

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03905161 on ClinicalTrials.gov